Predicting relapse and infection to optimize patient outcomes in ANCA-associated vasculitis: data from the MAINRITSAN trials cohort. (PubMed, Rheumatology (Oxford)) - Sep 29, 2026 - "The relapse prediction model demonstrated reproducible performance in this external validation cohort and may contribute to clinically relevant risk stratification, especially in PR3-ANCA patients. The infection model showed stronger predictive performance and may support individualized discussions regarding RTX extension."
Journal • ANCA Vasculitis • Diabetes • Infectious Disease • Metabolic Disorders • Otorhinolaryngology • Pulmonary Disease • Rare Diseases • Respiratory Diseases • Vasculitis
|
|
; Alexandre Karras; Antoine Néel; Benjamin Terrier; Catherine Hanrotel-Saliou; Eric Hachulla; Florence Delestre; François Lifermann; François Maurier; Grégory Pugnet; Jean-François Viallard; Loïc Guillevin; Maxime Samson; Nadine Meaux-Ruault; Nicolas Martin-Silva; Pascal Godmer; Pierre Charles; Raphaël Porcher; Stanislas Faguer; Thomas Le Gallou; Thomas Quéméneur; Xavier Puéchal
|